Physician profile
Joseph H Bee
NPI 1942431408
$1,594.90
in general payments reported to CMS, 2019-2025
14 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2021: $134 · 2022: $345 · 2023: $206 · 2024: $296 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $364.21 | 2019-2024 | |
| Genzyme Corporation | $295.38 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $285.69 | 2019-2024 | Dupixent, Libtayo |
| Glaxosmithkline, LLC. | $218.29 | 2021-2025 | Nucala |
| Aerin Medical INC. | $112.96 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $73.57 | 2022-2025 | Keytruda |
| Intersect Ent, INC. | $51.51 | 2021 | |
| Inspire Medical Systems, INC. | $49.09 | 2024-2025 | Inspire |
| Spirair, INC. | $43.79 | 2025 | Septalign, Turbalign |
| Medtronic, INC. | $25.77 | 2024 | Nim Vital |
| Alk-Abello, INC | $22.45 | 2021 | |
| Hikma Pharmaceuticals USA | $20.36 | 2022 | |
| Smith+Nephew, INC. | $17.11 | 2019 | |
| Stryker Corporation | $14.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.